AC Immune Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	27.74	36.28	78.49	31.59	82.22	160.89
Short-Term Investments	80.73	129.21	24.55	91	116	65
Cash & Short-Term Investments	108.47	165.49	103.05	122.59	198.22	225.89
Cash Growth	-31.30%	60.59%	-15.94%	-38.16%	-12.25%	-21.72%
Accounts Receivable	-	-	14.8	-	-	-
Other Receivables	1.58	1.1	0.62	0.39	0.43	0.33
Total Trade Receivables	1.58	1.1	15.42	0.39	0.43	0.33
Other Current Assets	3.7	5.4	6.68	5.12	3.99	5.55
Total Current Assets	113.75	171.99	125.15	128.09	202.63	231.77
Net Property, Plant & Equipment	6.86	8.09	6.88	7.07	8.03	6.64
Other Intangible Assets	50.42	50.42	50.42	50.42	50.42	-
Long-Term Investments	0.58	0.42	0.36	0.36	0.36	0.33
Total Assets	171.61	230.91	182.81	185.94	261.44	238.74
Accrued Expenses	11.99	12.1	11.09	9.42	16.74	11.09
Current Portion of Leases	1.05	1.03	0.67	0.55	0.57	0.44
Unearned Revenue	83.68	85.06	0.14	0.59	0.72	0.31
Other Current Liabilities	1.57	2.66	1.68	0.93	2	2.18
Total Current Liabilities	98.29	100.84	13.58	11.48	20.03	14.02
Long-Term Leases	3.62	4.4	2.83	2.25	2.34	1.78
Other Long-Term Liabilities	7.26	13.4	5.77	3.21	7.1	7.46
Total Long-Term Liabilities	10.88	17.81	8.6	5.47	9.44	9.24
Total Liabilities	109.16	118.64	22.17	16.95	29.46	23.26
Common Stock	2.24	2.23	2.09	1.8	1.79	1.54
Treasury Stock	-0.22	-0.22	-0.11	-0.12	-0.12	-0.1
Additional Paid-in Capital	480.17	478.51	474.91	431.32	431.25	346.89
Accumulated Other Comprehensive Income	0	-0.01	-0.05	-	-	-
Retained Earnings	-419.75	-368.24	-316.2	-264.02	-200.94	-132.85
Shareholders' Equity	62.44	112.27	160.64	168.99	231.98	215.48
Total Liabilities & Equity	171.61	230.91	182.81	185.94	261.44	238.74
Total Debt	4.66	5.43	3.5	2.8	2.91	2.22
Net Cash (Debt)	103.81	160.06	99.55	119.79	195.31	223.67
Net Cash Growth	-35.15%	60.78%	-16.89%	-38.67%	-12.68%	-21.71%
Net Cash Per Share	-	-	-	-	2.61	3.11
Book Value	62.44	112.27	160.64	168.99	231.98	215.48
Book Value Per Share	-	-	-	-	3.10	3.00
Tangible Book Value	12.03	61.85	110.23	118.58	181.56	215.48
Tangible Book Value Per Share	-	-	-	-	2.42	3.00

Updated Nov 4, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q